The goal of this decentralized, observational study is to enroll and observe adults inthe contingent United States during the 2023-2024 flu season. The main study objectivesare to create a dataset of paired wearable data, self-reported symptoms, and respiratoryviral infection (RVI) from PCR testing during the 2023-2024 flu season and to developalgorithm that is able to accurately classify asymptomatic and symptomatic RVI andunderstand the algorithm's performance metrics.
Not Provided
Inclusion Criteria:
- Lives in the United States
- Speaks, reads, and understands English
  -  Currently owns and uses a consumer wearable device (Apple Watch, Garmin, or Fitbit)
     with necessary step and heart rate data at minimum or willing to wear a
     study-provided device and download the Fitbit app
  -  Willing to connect their wearable device to the Evidation platform and wear it daily
     for at least 10 hours for the duration of the study
  -  Owns a smartphone with Apple iOS 15 installed or higher OR Android version 9.0
     installed or higher or willing to update
- Willing to respond to daily and weekly questionnaires for a 10-week period
  -  Willing to complete at-home nasal swab tests and return the nasal swab samples
     within 24 hours of being asked to complete it
- Meets data density requirements for wearable devices
Exclusion Criteria:
  -  Self reported diagnosis of both flu and COVID by a healthcare professional or using
     an at-home test in the past 3 months
  -  Currently enrolled in another interventional study to prevent or treat COVID-19 or
     another flu-related program being conducted by Evidation (individuals currently
     participating in Evidation's FluSmart program will be told that their participation
     will be paused)
  -  Has a primary mailing address that is a P.O box, Army Post Office (APO), Fleet Post
     Office (FPO), or Diplomatic Post Office (DPO) address, or U.S. military base located
     overseas, or U.S. territories (Puerto Rico, U.S. Virgin Islands, Guam, Northern
     Mariana Island, or American Samoa)
Evidation Health
San Mateo	5392423, California	5332921, United States
Ernesto Ramirez, PhD, Principal Investigator
 Evidation Health